Cangene corporation – product pipeline review – 2012


Published on

2012 || Cangene Corporation – Product Pipeline Review – 2012

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Cangene corporation – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Cangene Corporation – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Cangene Corporation - ProductPipeline Review - 2012” provides data on the Cangene Corporation’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Cangene Corporation’s corporate website, SEC filings,investor presentations and featured press releases, both from Cangene Corporationand industry-specific third party sources, put together by Global Markets Direct’steam.Scope- Cangene Corporation - Brief Cangene Corporation overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Cangene Corporation human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,
  2. 2. including the combination treatment modalities, across the globe.Table of contents:List of Tables 4List of Figures 4Cangene Corporation Snapshot 5Cangene Corporation Overview 5Key Information 5Key Facts 5Cangene Corporation – Research and Development Overview 6Key Therapeutic Areas 6Cangene Corporation – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Cangene Corporation – Pipeline Products Glance 10Cangene Corporation – Late Stage Pipeline 10Phase III Products/Combination Treatment Modalities 10Cangene Corporation – Early Stage Pipeline Products 11Pre-Clinical Products/Combination Treatment Modalities 11Cangene Corporation – Drug Profiles 12Anthrax Immune Globulin 12Product Description 12Mechanism of Action 12R&D Progress 12Botulism Antitoxin Heptavalent 13Product Description 13Mechanism of Action 13R&D Progress 13Ebola/Marburg Immune Globulins 15Product Description 15Mechanism of Action 15R&D Progress 15Immune Globulin Intravenous Program 16Product Description 16Mechanism of Action 16R&D Progress 16
  3. 3. List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Avir Green Hills Biotechnology AG – Product Pipeline Review – 2012BIOALVO S.A. – Product Pipeline Review – 2012Celator Pharmaceuticals, Inc. – Product Pipeline Review – 2012Cardio3 BioSciences SA – Product Pipeline Review – 2012Cornerstone Pharmaceuticals, Inc. – Product Pipeline Review – 2012Enzon Pharmaceuticals, Inc. – Product Pipeline Review – 2012iCo Therapeutics Inc. – Product Pipeline Review – 2012Neurocrine Biosciences, Inc. – Product Pipeline Review – 2012Mersana Therapeutics, Inc. – Product Pipeline Review – 2012Nexgenix Pharmaceuticals, LLC – Product Pipeline Review – 2012
  4. 4. Nuon Therapeutics, Inc. – Product Pipeline Review – 2012Osmotica Pharmaceutical Corp. – Product Pipeline Review – 2012SymBio Pharmaceuticals Limited – Product Pipeline Review – 2012ProStrakan Group plc – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: